Pyrimethamine (2,4-diamino-5-p-chlorophenyl-6-ethylpyrimidine), a dihydrofolate reductase (DHFR) inhibitor, is used for treating malaria by inhibiting the proliferation of plasmodium and toxoplasma and also applied to anti-tumor field [36]. The gene discussed is DHFR; the disease is neoplasm.